We are live on ! Find out more
BHC icon

Bausch Health

368 hedge funds and large institutions have $28.8B invested in Bausch Health in 2013 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 123 increasing their positions, 141 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $356M | Put options by funds: $222M

53% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 30

24% more capital invested

Capital invested by funds: $23.2B → $28.8B (+$5.56B)

3% more funds holding

Funds holding: 356368 (+12)

2% more funds holding in top 10

Funds holding in top 10: 4546 (+1)

1.12% less ownership

Funds ownership: 83.94%82.82% (-1.1%)

13% less repeat investments, than reductions

Existing positions increased: 123 | Existing positions reduced: 141

Holders
368
Holders Change
+12
Holders Change %
+3.37%
% of All Funds
11.93%
Holding in Top 10
46
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+2.22%
% of All Funds
1.49%
New
46
Increased
123
Reduced
141
Closed
30
Calls
$356M
Puts
$222M
Net Calls
+$134M
Net Calls Change
-$12.1M
Name Holding Trade Value Shares
Change
Change in
Stake
IIM
151
Ivory Investment Management
New York
$8.45M +$904K +9,282 +13%
HSBC Holdings
152
HSBC Holdings
United Kingdom
$8.37M +$1.35M +13,838 +21%
AP
153
Archon Partners
New Jersey
$8.26M -$1.83M -18,800 -19%
AC
154
Ascend Capital
California
$8.08M -$1.08M -11,072 -13%
New York State Common Retirement Fund
155
New York State Common Retirement Fund
New York
$7.97M +$7.44M +76,400 New
AIA
156
Avalon Investment & Advisory
Texas
$7.89M -$687K -7,054 -9%
FNBOO
157
First National Bank of Omaha
Nebraska
$7.86M -$960K -9,854 -12%
FPCM
158
Fox Point Capital Management
New York
$7.83M -$4.87M -50,000 -40%
CGI
159
CI Global Investments
California
$7.83M +$7.31M +75,000 New
BFA
160
BlackRock Fund Advisors
California
$7.82M -$744K -7,638 -9%
HAM
161
Highstreet Asset Management
Ontario, Canada
$7.66M -$307K -3,154 -4%
JAFL
162
Jay A. Fishman Ltd
Michigan
$7.52M +$168K +1,725 +2%
Arrowstreet Capital
163
Arrowstreet Capital
Massachusetts
$7.52M +$7.01M +71,988 New
VCM
164
Vigilant Capital Management
Maine
$7.5M +$126K +1,290 +2%
CBOA
165
Commonwealth Bank of Australia
Australia
$7.37M -$1.69M -17,344 -20%
STC
166
SEI Trust Company
Pennsylvania
$7.29M
AQR Capital Management
167
AQR Capital Management
Connecticut
$7.06M -$22.3M -228,547 -77%
CAM
168
Congress Asset Management
Massachusetts
$6.95M +$216K +2,218 +3%
PHS
169
PFM Health Sciences
California
$6.5M -$22.1M -226,769 -78%
Natixis Advisors
170
Natixis Advisors
Massachusetts
$6.48M +$359K +3,689 +6%
PPA
171
Parametric Portfolio Associates
Washington
$6.23M -$101K -1,037 -2%
TCM
172
Tributary Capital Management
Nebraska
$6.16M +$3.9K +40 +0.1%
SCM
173
Sigma Capital Management
Connecticut
$5.52M +$3.4M +34,900 +194%
BT
174
Beacon Trust
New Jersey
$5.42M
ZCM
175
Ziegler Capital Management
Illinois
$5.31M +$87.7K +900 +2%

BHC Hedge Fund Activity: Q3 2013 in Review

368 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q3 2013, worth a combined $28.8B — up 24% from $23.2B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new BHC positions and 30 closed out — a net gain of 16 holders — while 123 added to existing stakes and 141 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $215M. The largest seller was Visium Asset Management, exiting entirely with an estimated $132M sold.

  • 368 institutional investors held Bausch Health (BHC) as of Q3 2013, up from 356 in Q2 2013.
  • Funds reported $28.8B of Bausch Health stock for Q3 2013, up 24% quarter-over-quarter.
  • 46 funds opened new Bausch Health positions in Q3 2013 and 30 closed out, a net change of +16 holders.
  • The largest Bausch Health buyer in Q3 2013 was JP Morgan Chase, an estimated $215M added.
  • The largest Bausch Health seller in Q3 2013 was Visium Asset Management, an estimated $132M sold.

Based on aggregated 13F filings for Q3 2013.